Catalyst: Q4 Earnings Snapshot

In this article:

CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported fourth-quarter net income of $34.8 million.

The Coral Gables, Florida-based company said it had profit of 31 cents per share. Earnings, adjusted for pretax expenses and amortization costs, came to 53 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 48 cents per share.

The specialty drug company posted revenue of $110.6 million in the period, also exceeding Street forecasts. Five analysts surveyed by Zacks expected $105.8 million.

For the year, the company reported profit of $71.4 million, or 63 cents per share. Revenue was reported as $398.2 million.

Catalyst expects full-year revenue in the range of $455 million to $475 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CPRX at https://www.zacks.com/ap/CPRX

Advertisement